Please use this identifier to cite or link to this item:
http://sgc.anlis.gob.ar/handle/123456789/1614| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2020-06-21T16:00:33Z | - |
| dc.date.available | 2020-06-21T16:00:33Z | - |
| dc.date.issued | 2020-06-18 | - |
| dc.identifier.uri | https://tn.com.ar/salud/lo-ultimo/coronavirus-cinco-claves-del-suero-hiperinmune-de-caballo-que-se-probara-en-humanos_1083591 | - |
| dc.identifier.uri | http://sgc.anlis.gob.ar/handle/123456789/1614 | - |
| dc.description.abstract | Sería una alternativa de inmunización pasiva más efectiva para atenuar los efectos del COVID-19 a corto y mediano plazo. Esperan la aprobación de la ANMAT. | en_US |
| dc.publisher | TN | en_US |
| dc.subject | COVID19 | en_US |
| dc.subject | Medios de Comunicación | en_US |
| dc.subject | Suero Terapéutico COVID19 | en_US |
| dc.title | Coronavirus: cinco claves del suero hiperinmune de caballo que se probará en humanos | en_US |
| dc.type | Medios | en_US |
| item.cerifentitytype | Publications | - |
| item.grantfulltext | open | - |
| item.fulltext | With Fulltext | - |
| item.openairetype | Medios | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| Appears in Collections: | ANLIS frente a la epidemia COVID-19 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Coronavirus cinco claves del suero hiperinmune de caballo que será probado en humanos.pdf | 422.39 kB | Adobe PDF |  View/Open |
Page view(s)
133
checked on Oct 10, 2025
Download(s)
11
checked on Oct 10, 2025
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.